ID   PANC1/CD44v3-10
AC   CVCL_D2RB
DR   Wikidata; Q127383007
RX   PubMed=37489367;
RX   PubMed=37504249;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1681; CD44 (Note=Isoform v3-10; with a N-terminal GLEGGVAMPGAEDDVV = PA16-tag).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0480 ! PANC-1
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
RX   PubMed=37489367; DOI=10.3390/antib12030045; PMCID=PMC10366929;
RA   Suzuki H., Goto N., Tanaka T., Ouchida T., Kaneko M.K., Kato Y.;
RT   "Development of a novel anti-CD44 variant 8 monoclonal antibody
RT   C44Mab-94 against gastric carcinomas.";
RL   Antibodies (Basel) 12:45.1-45.17(2023).
//
RX   PubMed=37504249; DOI=10.3390/cimb45070333; PMCID=PMC10378409;
RA   Ishikawa K., Suzuki H., Kaneko M.K., Kato Y.;
RT   "Establishment of a novel anti-CD44 variant 10 monoclonal antibody
RT   C44Mab-18 for immunohistochemical analysis against oral squamous
RT   cell carcinomas.";
RL   Curr. Issues Mol. Biol. 45:5248-5262(2023).
//